Forward Citations = 50

Loading Chart...

8 inventors (with patents filed for the assignee):

Kenneth H Grabstein (4 out of 37 patents)

Natalie Winblade Nairn (3 out of 11 patents)

Aijun Wang (2 out of 8 patents)

4. Deepshikha Datta (2 out of 5 patents)

5. Stephen McCraith (2 out of 3 patents)

6. Thomas Graddis (2 out of 8 patents)

7. David A Tirrell (1 out of 21 patents)

8. Andrea Wang (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 10407482 - Amino acid substituted molecules (2019-09-10),

2. 8568706 - Modified human interferon-beta polypeptides (2013-10-29),

3. 7829659 - Methods of modifying polypeptides comprising non-natural amino acids (2010-11-09),

4. 7632492 - Modified human interferon-β polypeptides (2009-12-15),

Allozyne, Inc. is a biotechnology company that specializes in the development of protein therapeutics for the treatment of autoimmune and inflammatory diseases. The company's proprietary technology platform allows for the design and engineering of novel protein drugs with improved efficacy and safety profiles. Allozyne's mission is to address unmet medical needs and improve the lives of patients through innovative drug development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

4 Patents

#403 in Seattle, WA

#1,409 in Washington

#59,122 in US

Seattle, WA, United States of America

Allozyne, Inc.